Abstract
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a large number of studies are currently investigating ICBs in patients with hepatocellular carcinoma (HCC), alone or in...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have